MedPath

An evaluation of the successful excision of black mole using dermoscope.

Not Applicable
Conditions
Health Condition 1: L818- Other specified disorders of pigmentation
Registration Number
CTRI/2022/09/045833
Lead Sponsor
DR SHRIYA SIROHIYA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients of age 18 years and above.

2)Patients presenting with clinical features of Melanocytic nevi (who fit into the definition of melanocytic neoplasia) will be included in the study.

3)Patients who voluntarily request for the removal of the Melanocytic nevi.

4)Moles of size not more than 1 cm.

5)Patient who are willing to give informed written consent for enrollment into the study.

Exclusion Criteria

1)Patients who are not willing to give consent.

2)Irritated, infected or complicated melanocytic nevi.

3)Other causes of hyperpigmented macules and papules that do not fit into the definition of melanocytic nevi like seborrheic keratoses, ephelides, lentigines, melanoma, basal cell carcinoma, hemangioma, angioma angiokeratoma.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate dermoscopic findings of melanocytic nevi before shave excision and after healing of the excised site, in subjects seeking mole excision.Timepoint: 1. Baseline <br/ ><br>2. Post excision at(0-2 WEEKS) <br/ ><br>3. Follow up at (12 WEEKS) <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.To evaluate and correlate the clinical features of melanocytic nevi with its dermoscopic findings. <br/ ><br>2.To analyze dermoscopic findings of melanocytic nevi before and after shave excision. <br/ ><br>3.To evaluate prognosis of melanocytic nevi after shave excision. <br/ ><br>4.To examine and correlate histopathology of excised nevi with their dermoscopic findings.Timepoint: 1. Baseline <br/ ><br>2. Post excision at(0-2 WEEKS) <br/ ><br>3. Follow up at (12 WEEKS)
© Copyright 2025. All Rights Reserved by MedPath